Detalhe da pesquisa
1.
MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients.
Genes Chromosomes Cancer
; 61(3): 148-160, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841595
2.
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.
Breast Cancer Res Treat
; 195(3): 263-274, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984580
3.
High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer.
J Surg Oncol
; 125(4): 596-602, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34964996
4.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721561
5.
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Int J Cancer
; 147(8): 2303-2315, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270478
6.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
N Engl J Med
; 375(8): 717-29, 2016 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557300
7.
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.
Breast Cancer Res
; 19(1): 99, 2017 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851423
8.
A breast cancer gene signature for indolent disease.
Breast Cancer Res Treat
; 164(2): 461-466, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28451965
9.
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance.
Breast Cancer Res Treat
; 155(3): 463-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26820652
10.
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer.
Ann Surg
; 257(6): 1053-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23295318
11.
Obesity-associated changes in molecular biology of primary breast cancer.
Nat Commun
; 14(1): 4418, 2023 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37479706
12.
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response.
Breast Cancer Res Treat
; 133(1): 37-47, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21814749
13.
Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.
J Clin Oncol
; 40(12): 1335-1345, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35061525
14.
Impact of mammographic screening on the detection of good and poor prognosis breast cancers.
Breast Cancer Res Treat
; 130(3): 725-34, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21892702
15.
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
Breast Cancer Res Treat
; 119(3): 551-8, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19214742
16.
Clinical utility of the 70-gene MammaPrint profile in a Japanese population.
Jpn J Clin Oncol
; 40(6): 508-12, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20110242
17.
Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
Int J Cancer
; 125(6): 1390-7, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19536816
18.
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.
Breast Cancer Res Treat
; 116(2): 295-302, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18661261
19.
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Breast Cancer Res Treat
; 113(2): 275-83, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18311582
20.
Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.
Clin Cancer Res
; 14(10): 2988-93, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18483364